載入...
Germline pharmacogenomics in oncology: Decoding the patient for targeting therapy
Pharmacogenomics is the study of genetic factors determining drug response or toxicity. The use of pharmacogenomics is especially desirable in oncology because the therapeutic index of oncology drugs is often narrow, the need for favorable drug response is often acute, and the consequences of drug t...
Na minha lista:
| 發表在: | Mol Oncol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528362/ https://ncbi.nlm.nih.gov/pubmed/22321460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2012.01.005 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|